Attached

Listed Co AcquisitionStrategic Transactions View source PDF

LALPATHLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+11.6%1-day move

₹1374.00

prior close

₹1390.40

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.7+3.8+2.9+5.7+11.6+15.1+12.5+20.5+19.9+15.6+16.8+13.0+23.1—

Up moveDown movePending

AI summary

Dr. Lal PathLabs Limited has completed the acquisition of 100% stake in Shahbazkers Diagnostic Centre Private Limited (SDCPL) on May 1, 2026. The acquisition was carried out as per the terms and conditions of the Share Purchase Agreement. Following the completion, SDCPL has become a Wholly Owned Subsidiary of Dr. Lal PathLabs. The company had earlier informed about this acquisition on April 30, 2026, and has complied with disclosure requirements under SEBI regulations.

Likely market impact

The acquisition strengthens Dr. Lal PathLabs' market presence by making SDCPL its wholly owned subsidiary, potentially expanding its diagnostic services footprint and revenue base.